Breast dynamic contrast-enhanced examinations with fat suppression: Are contrast-agent uptake curves affected by magnetic field inhomogeneity?

European Radiology

Volumn 23, Issue 6, 2013, Pages 1537-1545

  Schmidt, Maria A ^a   Borri, M ^a   Scurr, E ^a   Ertas, G ^a   Payne, G ^a   O'Flynn, E ^a   Desouza, N ^a   Leach, M O ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast; Diagnostic techniques and procedures; Gadolinium compound; Magnetic resonance imaging; Neoplasms

Indexed keywords

FAT; WATER;

ADIPOSE TISSUE; ARTICLE; BREAST EXAMINATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHANCED EXAMINATION WITH FAT SATURATION; FEMALE; HUMAN; MAGNETIC FIELD; MAGNETIC FIELD HETEROGENEITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIGNAL DETECTION; WATER CONTENT;

ADIPOSE TISSUE; ALGORITHMS; BREAST; BREAST NEOPLASMS; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC FIELDS; REPRODUCIBILITY OF RESULTS; WATER;

EID: 84878688004     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2735-4     Document Type: Article

References (29)

1. Morrow M, Waters J, Morris E (2011) MRI for breast cancer screening, diagnosis, and treatment. Lancet 378:1804-1811
2. DeMartini W, Lehman C, Partridge S (2008) Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications. Acad Radiol 15:408-416
3. Van Goethem M, Verslegers I, Biltjes I, Hufkens G, Parizel PM (2009) Role of MRI of the breast in the evaluation of the symptomatic patient. Curr Opin Obstet Gynecol 21:74-79
4. Kuhl C, Kuhn W, Braun M, Schild H (2007) Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast 16:S34-S44
5. Plana MN, Carreira C, Muriel A, Chiva M, Abraira V, Emparanza JI, Bonfill X, Zamora J (2012) Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol 22:26-38
6. US Preventive Services Task Force (2009) Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 151:716-726
7. Saslow D, Boetes C, Burke W, et al. (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89
8. Lee CH, Dershaw DD, Kopans D, et al. (2010) Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7:18-27
9. Familial Breast Cancer. The Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care (Partial Update of NICE Clinical Guideline 14). National Institute for Health and Clinical Excellence, 2006 (NICE Clinical Guideline 41). Available http://www.nice.org.uk/ nicemedia/live/10994/30244/30244.pdf. Accessed 20/02/2012
10. Dall BJG, Gilbert F, Leach M, Wilson R (2009) Technical Guidelines for Magnetic Resonance Imaging for the Surveillance of Women at Increased Risk of Developing Breast Cancer. NHS Cancer Screening Programmes, (NHSBSP Publication No 68). Available https://www.nbss.nhs.uk/documents/ 1194%20MRI%20surveillance%20ed%20v6%203%2023%2012%2009.pdf Accessed 20/02/2012
11. American College of Radiology (2003) BI-RADS: MRI. In: Breast Imaging Reporting and Data System: BI-RADS Atlas, 4th edn. American College of Radiology, Reston
12. Leach MO, et al. (2005) MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778
13. Kriege M, Brekelmans CT, Boetes C, et al. (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437
14. Sardanelli F, Podo F, D'agnolo G, et al. (2007) Multicenter comparative multimodality surveillance of women at genetic familial high risk for breast cancer (HIBCRIT Study): interim results. Radiology 242:689-715
15. Warner E, Plewes DB, Hill KA, et al. (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. JAMA 292:1317-1325
16. Kuhl CK, Schrading S, Leutner CC, et al. (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476
17. Hagen AI, Kvistad KA, Maehle L, et al. (2007) Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 16:367-374
18. Lehman CD, BLume JD, Weatherall P, et al. (2005) Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103:1898-1905
19. Le-Petross HT, Whitman GJ, Atchley DP, Yuan Y, Gutierrez-Barrera A, Hortobagyi GN, Litton JK, Arun BK (2011) Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer. Cancer 117:3900-3907
20. Warner E, Causer PA, Wong JW, Wright FC, Jong RA, Hill KA, Messner SJ, Yaffe MJ, Narod SA, Plewes DB (2011) Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study. Breast J 17(1):9-17
21. Price J, Chen SW (2009) Screening for breast cancer with MRI: recent experience from the Australian Capital Territory. J Med Imaging Rad Oncol 53:69-80
22. Jansen SA, Shimauchi A, Zak L, et al. (2009) Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition. Am J Roentgenol 1993:832-839
23. Maril N, Collins CM, Greenman RL, Lenkinski RE (2005) Strategies for shimming the breast. Magn Reson Med 54:1139-1145
24. Haase A (1990) Snapshot FLASH MRI, applications to T1, T2 and chemical-shift imaging. Magn Reson Med 13:77-89
25. Mugler JP, Brookerman JR (1991) Rapid three-dimensional T1-weighted MR imaging with the MP-RAGE sequence. J Magn Reson Imaging 1:561-567
26. Di Giovanni P, Azlan CA, Ahearn TS, Semple SI, Gilbert FJ, Redpath TW (2010) The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T. Phys Med Biol 55:121-132
27. Rakow-Penner R, Daniel B, Yu H, Sawer-Glover A, Glover GH (2006) Relaxation times of breast tissue at 1.5 T and 3 T measured using IDEAL. J Mang Reson Imaging 23:87-91
28. De Naeyer D, Verhulst J, CeelenW SP, De Deene Y, Verdonck P (2011) Flip angle optimization fro dynamic contrast-enhanced MRI-studies with spoiled gradient echo pulse sequences. Phys Med Biol 56:5373-5395
29. Schabel MC, Parker DL (2008) Uncertainty and bias in contrast concentration measurements using spoiled gradient-echo pulse sequences. Phys Med Biol 53:2345-2373